Trial Summary
What is the purpose of this trial?This trial studies the use of a special type of computed (CT) scan called dual energy CT in detecting gastrointestinal carcinoid tumors. CT is an imaging technique that uses x-rays and a computer to create images of areas inside the body. Dual energy computed tomography is a technique used during routine CT scans to help obtain and process the image after the scan is complete. Doctors want to learn if dual energy computed tomography can help improve the detection of carcinoid tumors during routine CT scans.
Eligibility Criteria
This trial is for individuals with signs of carcinoid syndrome, increased markers indicating carcinoid, confirmed diagnosis through biopsy, or metastases known to be from a carcinoid tumor. They must be scheduled for a CT scan and have consented to participate. Pregnant individuals or those allergic to contrast agents used in scans cannot join.Inclusion Criteria
My biopsy confirmed I have carcinoid cancer.
My tests show markers indicating I might have carcinoid cancer.
My cancer spread is confirmed as carcinoid through a biopsy.
+3 more
Exclusion Criteria
My primary GI carcinoid tumor has been surgically removed.
Pregnant patients
I cannot have IV contrast due to an allergy, kidney issues, or pregnancy.
Participant Groups
The study is examining the effectiveness of Dual Energy Computed Tomography (DECT) in detecting gastrointestinal carcinoid tumors during routine CT scans. Researchers aim to determine if DECT can enhance the imaging and identification of these tumors.
1Treatment groups
Experimental Treatment
Group I: Diagnostic (dual energy CT scan)Experimental Treatment1 Intervention
Patients undergo one dual energy CT scan during scheduled CT scan.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
M D Anderson Cancer CenterHouston, TX
Loading ...
Who Is Running the Clinical Trial?
M.D. Anderson Cancer CenterLead Sponsor